+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Attenuation of colon inflammation through the RXR/PPARgamma heterodimer A basis for new therapeutic strategies



Attenuation of colon inflammation through the RXR/PPARgamma heterodimer A basis for new therapeutic strategies



Gastroenterology 120(5 Suppl. 1): A 686




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034457537

Download citation: RISBibTeXText


Related references

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. Journal of Experimental Medicine 193(7): 827-838, 2001

Attenuation of colon inflammation through activators of the retinoid X receptor /peroxisome proliferator-activated receptor gamma heterodimer A basis for new therapeutic strategies. Journal of Experimental Medicine 193(7): 827-838, 2001

Attenuation of colon inflammation through the mu-opioid receptor A basis for new therapeutic strategies. Gastroenterology 122(4 Suppl 1): A 5-A 6, 2002

Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer. Cancer Letters 240(2): 225-233, 2006

Attenuation of colonic inflammation by PPARgamma in intestinal epithelial cells: effect on Toll-like receptor pathway. Digestive Diseases and Sciences 51(4): 693-697, 2006

Inflammation-associated serum and colon markers as indicators of dietary attenuation of colon carcinogenesis in ob/ob mice. Cancer Prevention Research 2(1): 60-69, 2009

Activation of PPARgamma protects against colon inflammation by inhibiting TNFalpha signaling pathways. Gastroenterology 118(4 Suppl 2 Part 1): AGA A864, 2000

Promotion of colon tumors in C57BL/6J-APC(min)/+ mice by thiazolidinedione PPARgamma agonists and a structurally unrelated PPARgamma agonist. Toxicologic Pathology 32(1): 58-63, 2004

PER and TIM inhibit the DNA binding activity of a Drosophila CLOCK-CYC/dBMAL1 heterodimer without disrupting formation of the heterodimer: a basis for circadian transcription. Molecular and Cellular Biology 19(8): 5316-5325, 1999

1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways. Molecular Cancer Therapeutics 5(5): 1362-1370, 2006

Are physiological clonal expansion and maturation pathways a basis for discrepant behaviour of colon tumoral cell growth in response to the thiazolidinedione PPARgamma agonists?. Oncology Reports 6(6): 1281-1283, 1999

Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation. American Journal of Clinical Nutrition 91(1): 267s-272s, 2010

HIV protease inhibitors block human preadipocyte differentiation, but not via the PPARgamma/RXR heterodimer. Journal of Endocrinology 164(2): R7-R10, 2000

Effect of heterodimer partner RXRalpha on PPARgamma activation function-2 helix in solution. Biochemical and Biophysical Research Communications 365(1): 42-46, 2007

The thiazolidinedione-binding nuclear receptor PPARgamma mediates inhibition of glucagon gene transcription as a heterodimer with RXR. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl. 1): R23, 2003